Mesa Laboratories
MLAB
160 hedge funds and large institutions have $878M invested in Mesa Laboratories in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 59 increasing their positions, 49 reducing their positions, and 14 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 49
5% more capital invested
Capital invested by funds: $833M → $878M (+$45.2M)
7% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 14
0% more funds holding
Funds holding: 160 → 160 (0)
1.32% less ownership
Funds ownership: 95.22% → 93.9% (-1.3%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.09M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$4.72M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$2.36M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.94M |
| 5 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$1.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8.26M |
| 3 |
MAP
Moody Aldrich Partners
Marblehead,
Massachusetts
|
-$1.9M |
| 4 |
BlackRock
New York
|
-$1.8M |
| 5 |
Renaissance Technologies
New York
|
-$1.48M |
MLAB Hedge Fund Activity: Q1 2023 in Review
160 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q1 2023, worth a combined $878M — up 5.4% from $833M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new MLAB positions and 14 closed out — a net gain of 1 holder — while 59 added to existing stakes and 49 trimmed.
The largest buyer was Dimensional Fund Advisors, adding an estimated $5.09M. The largest seller was Point72 Asset Management, cutting an estimated $10.8M.
- 160 institutional investors held Mesa Laboratories (MLAB) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $878M of Mesa Laboratories stock for Q1 2023, up 5.4% quarter-over-quarter.
- 15 funds opened new Mesa Laboratories positions in Q1 2023 and 14 closed out, a net change of +1 holder.
- The largest Mesa Laboratories buyer in Q1 2023 was Dimensional Fund Advisors, an estimated $5.09M added.
- The largest Mesa Laboratories seller in Q1 2023 was Point72 Asset Management, an estimated $10.8M sold.
Based on aggregated 13F filings for Q1 2023.